drugset / Trial / NCT03310073
Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV
NaSingle-groupOpen-labelPrevention
Summary
This study is to assess protectivity following four doses of bOPV which given simultaneously with Pentabio® and 1 dose of IPV at the 4th visit
Timeline
- Start
- 2016-07
- Primary completion
- 2017-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bOPV | Vaccine | 0.1 ml | Oral |
| Background | IPV | Unknown | — | Intramuscular |
| Background | Pentabio | Vaccine | — | Intramuscular |
Indications
No indication recorded.